According to UnivDatos Market Insights (UMI)’ research report “global vascular stent market”, the market is expected to witness a growth of around 7% during the forecast period 2021-2027F. The market is growing due to the rise in the prevalence of the rising geriatric population coupled with aortic diseases around the globe. Moreover, the increase in demand for non-invasive surgical procedures is widening the scope of growth for the vascular stent market. Moreover, stringent government regulations coupled with the growing focus of major stakeholders in the healthcare industry is fueling the market growth. The advancements in medical technology and the introduction of a variety of stents are the important factors that drive the market of the vascular stent market. Moreover, the changing lifestyle preferences have significantly increased the diseases such as diabetes and obesity that are responsible for increasing cardiac disorders. As a result, the growing burden of aortic diseases is facilitated the vascular stent market growth across the globe.
Unlock The Table of Content, And Request a
Sample Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=28711
Based on the type, the market is
categorized into bare-metal stents, drug-eluting stents, and bioabsorbable
stents. The drug-eluting stents segment held a significant market in 2020 and
it is anticipated to grow during the forecast period. The rapidly increasing
number of cases of coronary heart disease induces the demand for a better and
improved version of the stents responsible for the segmental growth of
drug-eluting stents. Furthermore, frequent launches of new-generation stents
are responsible for the segmental growth of drug-eluting stents.
Based on the mode of delivery, the market is
segmented into balloon-expandable stents and self-expanding stents. The
balloon-expandable stents held a significant market share and are anticipated
to witness significant growth during the forecast period. This is mainly due to
the increasing complexity of heart surgeries and their accuracy during the
stent placement. Furthermore, the advancement in stent technology also favors
the growth of the segment in the vascular stent market.
Unlock The Table of Content, And Request a
Sample Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=28711
North America to
witness significant growth
For a
better understanding of the market adoption of the vascular stent, the market
is analyzed based on its worldwide presence in the countries such as North
America (US, Canada, Rest of North America); Europe (Germany, UK, France,
Italy, Spain, and Rest of Europe); Asia-Pacific (China, Japan, India,
Australia, Rest of Asia-Pacific), and Rest of World. North America grabbed a significant market
share of the global vascular stent market in 2020. It is expected to grow with
a considerable CAGR during the forecast period. The major factors such as
sophisticated healthcare infrastructure, the presence of a large population,
the rise in cardiac disease incidence, the aging population, the rising
prevalence of peripheral arterial disease, and increasing investments by
investors are propelling the growth of this market. For instance, as per
CDC, approximately 8 million people in the United States have peripheral
arterial disease, including 12-20% of individuals older than age 60.
For More Informative Information, Please Visit
Us – https://univdatos.com/report/vascular-stent-market/
According
to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the vascular
stent market include are Abbott, Medtronic, Boston Scientific Corporation, Terumo
Corporation, B Braun Melsungen AG, Biotronik, Stentys SA, MicroPort Scientific
Corporation, C. R. Bard, Inc., and Cook Medical, among others. The players are focused
on launching products for gaining customers' traction and expanding their
geographical reach to get a competitive edge in the industry.
“Global Vascular
Stent Market Analysis, 2021” provides comprehensive qualitative and
quantitative insights on the industry potential, key factors impacting sales
and purchase decisions, hotspots, and opportunities available for Vascular
stent providers across the Globe. Moreover, the report also encompasses the key
strategic imperatives for success for competitors along with strategic
factorial indexing measuring competitors’ capabilities on 16 parameters. This
will help companies in the formulation of go to Market Strategies and
identifying the blue ocean for its offerings.
Market Segmentation:
1. By Product(Coronary Stent, Peripheral Stent, EVAR Stent
Grafts, Others)
2. By Type (Bare-Metal Stents, Drug-Eluting
Stents, and Bioabsorbable Stents)
3. By Mode of Delivery (Balloon expandable Stents and Self-expanding
Stents)
4. By
End-users (Hospitals & Clinics, Ambulatory Surgical Centers, and Others)
5.
By Region (North America,
Europe, Asia-Pacific, Rest of the World)
6.
By Company (Abbott, Medtronic, Boston
Scientific Corporation, Terumo Corporation, B Braun Melsungen AG, Biotronik,
Stentys SA, MicroPort Scientific Corporation, C. R. Bard, Inc., and Cook
Medical., etc.)
Comments